Generics and Biosimilars: Sorting out Fact From Fiction

Sponsored by Sandoz

22 Aug 2024 | ~57:11 Engagement Time

Presenters

Roz Kalb , Psychologist , Nancy Sicotte , Neurologist & Bari Talente , EVP, Advocacy and Healthcare Access, NMSS

On This Page

Related Resources

Biosimilar Medications and MS: What You Need To Know

Derrick Robertson , Neurologist & Stephanie Buxhoeveden , PhD, MSCN, MSN, FNP-BC

Doctor, brochure and medical patient consulting about health while learning about healthcare at office desk. Man, GP and support communication for woman on safety from virus, disease or sickness.

Generics and Biosimilars | 7 Important Questions, Answered

Kathy Costello , Nurse Practitioner

Webinar Recording

Special Webinar - Generics and Biosimilars: Sorting out Fact From Fiction Thumbnail

Overview

Generic and biosimilar drugs have entered the MS treatment scene. Learn the facts to help you prepare for treatment decisions with your MS provider. In this webinar we’ll address the basics of generics vs. biosimilars such as what they are, how they’re developed and approved by the FDA, or whether they’re as effective as other treatments on the market. In addition, we’ll address concerns about having to switch from the DMT you’re on and whether insurance will pay for these new options.

Downloads

  • PDF

    Presentation Slides